Intuitive Surgical (ISRG)
(Delayed Data from NSDQ)
$484.40 USD
-4.67 (-0.95%)
Updated Sep 24, 2024 04:00 PM ET
After-Market: $484.61 +0.21 (0.04%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth C Momentum D VGM
Price, Consensus and EPS Surprise
ISRG 484.40 -4.67(-0.95%)
Will ISRG be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ISRG based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for ISRG
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know
Here's Why Intuitive Surgical, Inc. (ISRG) Gained But Lagged the Market Today
ISRG: What are Zacks experts saying now?
Zacks Private Portfolio Services
Is It Worth Investing in Intuitive Surgical (ISRG) Based on Wall Street's Bullish Views?
Intuitive Surgical, Inc. (ISRG) Stock Falls Amid Market Uptick: What Investors Need to Know
Is Phibro Stock Worth Retaining in Your Portfolio Now?
Other News for ISRG
ISRG September 2025 Options Begin Trading
Intuitive Surgical: A Growth Machine - But Valuation? That's Another Story
Intuitive Surgical Stock Is Too Hot To Touch
Intuitive Surgical Offers Low Risk, High Return Despite Valuation Concerns
Orbimed Advisors LLC Reduces Stake in Traws Pharma Inc